Ghourab S
Department of Obstetrics and Gynecology, King Khalid University Hospital, King Saud University, PO Box 2925, Riyadh 11461, Kingdom of Saudi Arabia.
Saudi Med J. 2001 Oct;22(10):914-6.
Over the last 2 decades great concern about the possible association between ovarian cancer and ovulation induction has been raised. Between the first reported case in 1982 and the end of year 2000, there have been 44 cases of ovarian carcinoma reported to occur in women previously treated with ovulation induction drugs. Most of these tumors were of the serous type with low malignant potential. In the present case, the patient had secondary anovulatory infertility and previous left cystoophorectomy for ovarian endometrioma. She was treated with human menopausal gonadotrophin alone or in combination with clomiphene citrate for 13 cycles prior to presentation. Screening ultrasound revealed multicystic right ovarian mass (15 x 9 x 6 cm). Hysterectomy and right salpingo-oophorectomy were carried out. Intraoperative and histological examinations showed stage 1A endometrioid ovarian cancer and well-differentiated endometrial adenoacanthoma with minimal myometrial invasion. A brief but critical review of published literature regarding the association of ovulation induction and increased risk of ovarian cancer is presented.
在过去20年里,人们对卵巢癌与促排卵之间可能存在的关联极为关注。从1982年首例报告病例到2000年底,已有44例卵巢癌病例报告发生在先前接受过促排卵药物治疗的女性身上。这些肿瘤大多为低恶性潜能的浆液性类型。在本病例中,患者继发无排卵性不孕,既往因卵巢子宫内膜异位症行左侧卵巢囊肿切除术。在就诊前,她单独使用人绝经期促性腺激素或与人绝经后促性腺激素联合使用克罗米芬进行了13个周期的治疗。筛查超声显示右侧卵巢多囊性肿块(15×9×6cm)。进行了子宫切除术和右侧输卵管卵巢切除术。术中及组织学检查显示为1A期子宫内膜样卵巢癌和高分化子宫内膜腺棘皮瘤,肌层浸润极少。本文对已发表的关于促排卵与卵巢癌风险增加之间关联的文献进行了简要但关键的综述。